Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1745-6215
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial ; volume:21 ; number:1 ; day:27 ; month:10 ; year:2020 ; pages:1-12 ; date:12.2020
Trials ; 21, Heft 1 (27.10.2020), 1-12, 12.2020

Urheber
Acharya, Nisha R.
Ebert, Caleb D.
Kelly, Nicole K.
Porco, Travis C.
Ramanan, Athimalaipet V.
Arnold, Benjamin F.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13063-020-04796-z
URN
urn:nbn:de:101:1-2020121118582767670520
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:29 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Acharya, Nisha R.
  • Ebert, Caleb D.
  • Kelly, Nicole K.
  • Porco, Travis C.
  • Ramanan, Athimalaipet V.
  • Arnold, Benjamin F.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab

Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab

Juvenile idiopathic arthritis-associated uveitis

Juvenile idiopathic arthritis-associated uveitis

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis

Adalimumab treatment in Juvenile Idiopathic Arthritis (JIA) patients with special focus on Uveitis

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases

Efficacy of adalimumab in refractory juvenile idiopathic arthritis related uveitis: report of 6 cases

Perinatal events and development of juvenile idiopathic arthritis-associated uveitis

Perinatal events and development of juvenile idiopathic arthritis-associated uveitis

Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis

Adalimumab-induced manic episode in an adolescent with juvenile idiopathic arthritis

Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient

Juvenile idiopathische Arthritis – Adalimumab – sicher und effizient

Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice

Immunomodulatory treatment and surgical management of idiopathic uveitis and juvenile idiopathic arthritis-associated uveitis in children: a French survey practice

Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab

Administration of routine preventative vaccinations in children with polyarticular juvenile idiopathic arthritis receiving adalimumab

Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab

Juvenile idiopathische Arthritis – Langzeitsicherheit von Etanercept und Adalimumab

Haptoglobin in Juvenile Idiopathic Arthritis

Haptoglobin in Juvenile Idiopathic Arthritis

Ultrasound in juvenile idiopathic arthritis

Ultrasound in juvenile idiopathic arthritis

Verbundene Objekte